Direct effect of cholesterol on insulin secretion: A novel mechanism for pancreatic β-cell dysfunction

Diabetes

Volumn 56, Issue 9, 2007, Pages 2328-2338

  Hao, Mingming ^a   Head, W Steven ^a   Gunawardana, Subhadra C ^a   Hasty, Alyssa H ^a   Piston, David W ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FATTY ACID; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOWN REGULATION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; INSULIN BLOOD LEVEL; INSULIN RELEASE; LIPID DIET; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; CELL SURVIVAL; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, NONESTERIFIED; GLUCOKINASE; GLUCOSE; HUMANS; HYPERLIPIDEMIAS; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MEVALONIC ACID; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE I;

EID: 34548386258     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db07-0056     Document Type: Article

References (50)

1. Yki-Jarvinen H: Pathogenesis of non-insulin-dependent diabetes mellitus. Lancet 343:91-95, 1994
2. Kahn SE: The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46:3-19, 2003
3. Lyssenko V, Almgren P, Anevski D, Perfekt R, Lahti K, Nissen M, Isomaa B, Forsen B, Homstrom N, Saloranta C, Taskinen MR, Groop L, Tuomi T: Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes. Diabetes 54:166-174, 2005
4. Unger RH: Lipotoxicity in the pathogenesis of obesity-dependent NIDDM: genetic and clinical implications. Diabetes 44:863-870, 1995
5. Yaney GC, Corkey BE: Fatty acid metabolism and insulin secretion in pancreatic beta cells. Diabetologia 46:1297-1312, 2003
6. Brown MS, Goldstein JL: The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89:331-340, 1997
7. Le Lay S, Krief S, Farnier C, Lefrere I, Le Liepvre X, Bazin R, Ferre P, Dugail I: Cholesterol, a cell size-dependent signal that regulates glucose metabolism and gene expression in adipocytes. J Biol Chem 276:16904-16910, 2001
8. Warnock DE, Roberts C, Lutz MS, Blackburn WA, Young WW Jr, Baenziger JU: Determination of plasma membrane lipid mass and composition in cultured Chinese hamster ovary cells using high gradient magnetic affinity chromatography. J Biol Chem 268:10145-10153, 1993
9. Hao M, Lin SX, Karylowski OJ, Wustner D, McGraw TE, Maxfield FR: Vesicular and non-vesicular sterol transport in living cells: the endocytic recycling compartment is a major sterol storage organelle. J Biol Chem 277:609-617, 2002
10. Simons K, Ikonen E: Functional rafts in cell membranes. Nature 387:569-572, 1997
11. Brown DA, London E: Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol Chem 275:17221-17224, 2000
12. Xu X, London E: The effect of sterol structure on membrane lipid domains reveals how cholesterol can induce lipid domain formation. Biochemistry 39:843-849, 2000
13. Xia F, Gao X, Kwan E, Lam PP, Chan L, Sy K, Sheu L, Wheeler MB, Gaisano HY, Tsushima RG: Disruption of pancreatic beta-cell lipid rafts modifies Kv2.1 channel gating and insulin exocytosis. J Biol Chem 279:24685-24691, 2004
14. Takahashi N, Hatakeyama H, Okado H, Miwa A, Kishimoto T, Kojima T, Abe T, Kasai H: Sequential exocytosis of insulin granules is associated with redistribution of SNAP25. J Cell Biol 165:255-262, 2004
15. Veluthakal R, Chvyrkova I, Tannous M, McDonald P, Amin R, Hadden T, Thurmond DC, Quon MJ, Kowluru A: Essential role for membrane lipid rafts in interleukin-1β-induced nitric oxide release from insulin-secreting cells: potential regulation by caveolin-1+. Diabetes 54:2576 -2585, 2005
16. Gruen ML, Saraswathi V, Nuotio-Antar AM, Plummer MR, Coenen KR, Hasty AH: Plasma insulin levels predict atherosclerotic lesion burden in obese hyperlipidemic mice. Atherosclerosis 186:54-64, 2006
17. Hao M, Li X, Rizzo MA, Rocheleau JV, Dawant BM, Piston DW: Regulation of two insulin granule populations within the reserve pool by distinct calcium sources. J Cell Sci 118:5873-5884, 2005
18. Hohmeier HE, Mulder H, Chen G, Henkel-Rieger R, Prentki M, Newgard CB: Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes 49:424-430, 2000
19. Gunawardana SC, Rocheleau JV, Head WS, Piston DW: Mechanisms of time-dependent potentiation of insulin release: involvement of nitric oxide synthase. Diabetes 55:1029-1033, 2006
20. Mayor S, Sabharanjak S, Maxfield FR: Cholesterol-dependent retention of GPI-anchored proteins in endosomes. Embo J 17:4626-4638, 1998
21. Goward CR, Hartwell R, Atkinson T, Scawen MD: The purification and characterization of glucokinase from the thermophile Bacillus stearothermophilus. Biochem J 237:415-420, 1986
22. Rizzo MA, Magnuson MA, Drain PF, Piston DW: A functional link between glucokinase binding to insulin granules and conformational alterations in response to glucose and insulin. J Biol Chem 277:34168-34175, 2002
23. Vidal J, Verchere CB, Andrikopoulos S, Wang F, Hull RL, Cnop M, Olin KL, LeBoeuf RC, O'Brien KD, Chait A, Kahn SE: The effect of apolipoprotein E deficiency on islet amyloid deposition in human islet amyloid polypeptide transgenic mice. Diabetologia 46:71-79, 2003
24. D'Ambra R, Surana M, Efrat S, Starr RG, Fleischer N: Regulation of insulin secretion from beta-cell lines derived from transgenic mice insulinomas resembles that of normal beta-cells. Endocrinology 126:2815-2822, 1990
25. Gee KR, Zhou ZL, Qian WJ, Kennedy R: Detection and imaging of zinc secretion from pancreatic beta-cells using a new fluorescent zinc indicator. J Am Chem Soc 124:776-778, 2002
26. Bennett BD, Jetton TL, Ying G, Magnuson MA, Piston DW: Quantitative subcellular imaging of glucose metabolism within intact pancreatic islets. J Biol Chem 271:3647-3651, 1996
27. Postic C, Shiota M, Magnuson MA: Cell-specific roles of glucokinase in glucose homeostasis. Recent Prog Horm Res 56:195-217, 2001
28. Gloyn AL: Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy. Hum Mutat 22:353-362, 2003
29. Rizzo MA, Piston DW: Regulation of beta cell glucokinase by S-nitrosylation and association with nitric oxide synthase. J Cell Biol 161:243-248, 2003
30. Yancey PG, Rodrigueza WV, Kilsdonk EP, Stoudt GW, Johnson WJ, Phillips MC, Rothblat GH: Cellular cholesterol efflux mediated by cyclodextrins. Demonstration Of kinetic pools and mechanism of efflux. J Biol Chem 271:16026-16034, 1996
31. Ort T, Maksimova E, Dirkx R, Kachinsky AM, Berghs S, Froehner SC, Solimena M: The receptor tyrosine phosphatase-like protein ICA512 binds the PDZ domains of beta2-syntrophin and nNOS in pancreatic beta-cells. Eur J Cell Biol 79:621-630, 2000
32. Ghosh DK, Abu-Soud HM, Stuehr DJ: Domains of macrophage N(O) synthase have divergent roles in forming and stabilizing the active dimeric enzyme. Biochemistry 35:1444-1449, 1996
33. Tzeng E, Billiar TR, Robbins PD, Loftus M, Stuehr DJ: Expression of human inducible nitric oxide synthase in a tetrahydrobiopterin (H4B)-deficient cell line: H4B promotes assembly of enzyme subunits into an active dimer. Proc Natl Acad Sci U S A 92:11771-11775, 1995
34. Klatt P, Schmidt K, Lehner D, Glatter O, Bachinger HP, Mayer B: Structural analysis of porcine brain nitric oxide synthase reveals a role for tetrahydrobiopterin and L-arginine in the formation of an SDS-resistant dimer. Embo J 14:3687-3695, 1995
35. Lajoix AD, Pugniere M, Roquet F, Mani JC, Dietz S, Linck N, Faurie F, Ribes G, Petit P, Gross R: Changes in the dimeric state of neuronal nitric oxide synthase affect the kinetics of secretagogue-induced insulin response. Diabetes 53:1467-1474, 2004
36. de Bont N, Netea MG, Demacker PN, Verschueren I, Kullberg BJ, van Dijk KW, van der Meer JW, Stalenhoef AF: Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection. J Lipid Res 40:680-685, 1999
37. Roehrich ME, Mooser V, Lenain V, Herz J, Nimpf J, Azhar S, Bideau M, Capponi A, Nicod P, Haefliger JA, Waeber G: Insulin-secreting beta-cell dysfunction induced by human lipoproteins. J Biol Chem 278:18368-18375, 2003
38. Gao J, Katagiri H, Ishigaki Y, Yamada T, Ogihara T, Imai J, Uno K, Hasegawa Y, Kanzaki M, Yamamoto TT, Ishibashi S, Oka Y: Involvement of apolipoprotein E in excess fat accumulation and insulin resistance. Diabetes 56:24-33, 2007
39. Goldstein JL, Brown MS: Molecular medicine: the cholesterol quartet. Science 292:1310-1312, 2001
40. Simons K, Ehehalt R: Cholesterol, lipid rafts, and disease. J Clin Invest 110:597-603, 2002
41. Abulrob A, Tauskela JS, Mealing G, Brunette E, Faid K, Stanimirovic D: Protection by cholesterol-extracting cyclodextrins: a role for N-methyl-D-aspartate receptor redistribution. J Neurochem 92:1477-1486, 2005
42. Hao M, Mukherjee S, Sun Y, Maxfield FR: Effects of cholesterol depletion and increased lipid unsaturation on the properties of endocytic membranes. J Biol Chem 279:14171-14178, 2004
43. Dhanvantari S, Loh YP: Lipid raft association of carboxypeptidase E is necessary for its function as a regulated secretory pathway sorting receptor. J Biol Chem 275:29887-29893, 2000
44. Gondre-Lewis MC, Petrache HI, Wassif CA, Harries D, Parsegian A, Porter FD, Loh YP: Abnormal sterols in cholesterol-deficiency diseases cause secretory granule malformation and decreased membrane curvature. J Cell Sci 119:1876-1885, 2006
45. Arya R, Duggirala R, Almasy L, Rainwater DL, Mahaney MC, Cole S, Dyer TD, Williams K, Leach RJ, Hixson JE, MacCluer JW, O'Connell P, Stern MP, Blangero J: Linkage of high-density lipoprotein-cholesterol concentrations to a locus on chromosome 9p in Mexican Americans. Nat Genet 30:102-105, 2002
46. Freeman DJ, Norrie J, Sattar N, Neely RD, Cobbe SM, Ford I, Isles C, Lorimer AR, Macfarlane PW, McKillop JH, Packard CJ, Shepherd J, Gaw A: Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation 103:357-362, 2001
47. Briones ER, Steiger DL, Palumbo PJ, O'Fallon WM, Langworthy AL, Zimmerman BR, Kottke BA: Sterol excretion and cholesterol absorption in diabetics and nondiabetics with and without hyperlipidemia. Am J Clin Nutr 44:353-361, 1986
48. Gylling H, Miettinen TA: Cholesterol absorption, synthesis, and LDL metabolism in NIDDM. Diabetes Care 20:90-95, 1997
49. Stranberg TE, Salomaa V, Vanhanen H, Miettinen TA: Associations of fasting blood glucose with cholesterol absorption and synthesis in nondiabetic middle-aged men. Diabetes 45:755-761, 1996
50. Sutherland WH, Scott RS, Lintott CJ, Robertson MC, Stapely SA, Cox C: Plasma non-cholesterol sterols in patients with non-insulin dependent diabetes mellitus. Horm Metab Res 24:172-175, 1992